(2E)-1-(3-bromophenyl)-3-(3-nitrophenyl)prop-2-en-1-one, 95.0%, 10g

N-[(1R*,4R*)-4-Aminocyclohexyl]-4-chlorobenzamide hydrochloride, 1g

4-Methyl-2-nitrobenzaldehyde, 95.0%, 250mg

Ethyl 5-amino-2-methylnicotinate, 95.0%, 5g

3-Bromo-N1-methylbenzene-1,2-diamine, 95.0%, 250mg

(S)-2,5-Diaminopentanoic acid compound with 2-oxopentanedioic acid (1:1), 95.0%, 5kg

4-Bromo-5-chloro-2-nitroaniline, 90.0%, 10g

N-{1-Butylcarbamoyl-2-[5-(4-nitro-phenyl)-furan-2--yl]-vinyl}-4-methyl-benzamide, 1mg

(6-Methylpyridin-3-yl)methanamine, 95.0%, 1g

2-[4-(2-Dimethylamino-5-trifluoromethyl-pyridin-3-yl)-phenoxy]-propionic acid, 95.0%, 1g

4,6-DICHLORO-3-METHYL-1H-PYRAZOLO[4,3-C]PYRIDINE, 95%, 1g

2-(Prop-1-en-2-yl)aniline, 95.0%, 5g

DORAMAPIMOD, 98%, 5g